A 25-gene classifier predicts overall survival in resectable pancreatic cancer

A 25-gene classifier predicts overall survival in resectable pancreatic cancer

Abstract Background Pancreatic carcinoma is one of the most lethal human cancers. In patients with resectable tumors, surgery followed by adjuvant chemotherapy is the only curative treatment. However, the 5-year survival is 20%. Because of a strong metastatic propensity, neoadjuvant chemotherapy is...

Full description

Bibliographic Details
Main Authors: David J. Birnbaum, Pascal Finetti, Alexia Lopresti, Marine Gilabert, Flora Poizat, Jean-Luc Raoul, Jean-Robert Delpero, Vincent Moutardier, Daniel Birnbaum, Emilie Mamessier, François Bertucci
Format: Article
Language:English
Published: BMC 2017-09-01
Series:BMC Medicine
Subjects:
Expression profiling
Pancreatic cancer
Prognosis
Survival
Online Access:http://link.springer.com/article/10.1186/s12916-017-0936-z

Internet

http://link.springer.com/article/10.1186/s12916-017-0936-z

Similar Items